Tags: Heart Disease | heart | failure | drug | corlanor | treatment

New Type of Heart Failure Drug OKd by FDA

Wednesday, 15 April 2015 05:07 PM

Patients with chronic heart failure, a deadly disease that worsens as the heart pumps less blood through the body, are getting a much-needed new option.

The Food and Drug Administration has approved a novel drug from Amgen for reducing hospitalizations in some heart failure patients.

Corlanor (coor'LAHN'-or) is the first medication in a dozen years for the increasingly common condition.

Chronic heart kills up to half of patients within five years, despite numerous existing treatments.

Rival drugmaker Novartis has another heart failure pill under review by the FDA. It could be approved this summer.

Roughly 6 million Americans and 26 million people worldwide have heart failure, mostly as a chronic condition.

It's becoming more common along with obesity and because more people survive heart attacks due to better treatments.

© Copyright 2019 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

   
1Like our page
2Share
Health-News
Patients with chronic heart failure, a deadly disease that worsens as the heart pumps less blood through the body, are getting a much-needed new option. The Food and Drug Administration has approved a novel drug from Amgen for reducing hospitalizations in some heart failure...
heart, failure, drug, corlanor, treatment
129
2015-07-15
Wednesday, 15 April 2015 05:07 PM
Newsmax Media, Inc.
 

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved